Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance

Diabetes Research and Clinical Practice

Volumn 76, Issue 3, 2007, Pages 351-357

  Palik, Eva ^a   Baranyi, Eva ^b   Melczer, Zsolt ^c   Audikovszky, Maria ^d   Szöcs, Albert ^f   Winkler, Gábor ^e   Cseh, Károly ^f  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Szent Imre Hospital   (Hungary)

^e ST JOHN'S HOSPITAL   (Hungary)

^f Karolyi Hospital   (Hungary)

Author keywords

Cytokines; Gestational diabetes mellitus; Ghrelin; Insulin resistance; Pregnancy; Resistin

Indexed keywords

ADIPONECTIN; C PEPTIDE; GHRELIN; GLUCOSE; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACYLATION; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN;

BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MULTIVARIATE ANALYSIS; PEPTIDE HORMONES; PREGNANCY; PREGNANCY TRIMESTERS; RECEPTORS, TUMOR NECROSIS FACTOR; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947590069     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.09.005     Document Type: Article

References (22)

1. Winkler G., Cseh K., Baranyi E., Melczer Zs., Speer G., Hajós P., et al. Tumor necrosis factor system in insulin resistance in patients with gestational diabetes. Diab. Res. Clin. Pract. 56 (2002) 93-99
2. Cseh K., Baranyi E., Melczer Zs., Csákány G.M., Kovács M., Gero{combining double acute accent} G., et al. The pathophysiological influence of leptin and tumor necrosis factor system on maternal insulin resistance: negative correlations with anthropometric parameters of neonates in gestational diabetes. Gynecol. Endocrinol. 16 (2002) 453-460
3. Cseh K., Baranyi E., Melczer Zs., Kaszás E., and Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 27 (2004) 274-275
4. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Denghenghi R., et al. Expression of ghrelin and GHS receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 87 (2002) 1300-1308
5. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., et al. The expression of the growth hormone secretagogue ligand, ghrelin in normal and abnormal human pituitary and other neuroendocrine tissues. J. Clin. Endocrinol. Metab. 86 (2001) 881-887
6. Vang G., Lee H.-M., Englander E., and Greeley G.H. Ghrelin-not just an other stomach hormone. Regul. Pept. 105 (2002) 75-81
7. De Ambrogi M., Volpe S., and Tamanini T. Ghrelin: central and peripheral effects of a novel peptidyl homone. Med. Sci. Monit. 9 (2003) RA217-RA224
8. Korbonits M., Goldstone A.P., Gueorguiev M., and Grossman A.B. Ghrelin-a hormone with multiple functions. Front. Neuroendocrinol. 25 (2004) 27-68
9. Steppan C.M., and Lazar M.A. Resistin and obesity associated insulin resistance. Trends Endocrinol. Metab. 13 (2002) 18-22
10. Adeghate E. An update on the biology and physiology of resistin. Cell. Mol. Life. Sci. 61 (2004) 2485-2496
11. Lehrke M., Reilly N.P., Millington S.C., Iqbal N., Rader D.J., and Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. PLOS Med. 1 (2004) 161-168
12. Berg A.H., Combs T.P., and Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13 (2002) 84-89
13. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications, Report of a WHO consultation, Part I: Diagnosis and classification of diabetes mellitus, WHO, Geneva, 1999.
14. Lee W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
15. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression in human monocytes and T-cells. J. Clin. Invest. 114 (2004) 57-66
16. Asakawa A., Inui A., Kaga T., Katsuura J., Fujimya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gout 52 (2003) 947-952
17. Watmore A.J., Hall C.N., Jones J., Westwood M., and Clayton P.E. Ghrelin concentration in healthy children and adolescents. Clin. Endocrinol. (Oxf) 59 (2003) 649-654
18. Ng P.C., Lee C.H., Lam C.W., Wong E., Chan I.H., and Fok T.F. Plasma ghrelin and resistin concetrations are suppressed in infants of insulin-dependent diabetic mothers. J. Clin. Endocrinol. Metab. 89 (2004) 5560-5568
19. Fuglsang J., Skjaerbaek C., Espelund U., Frystys J., Fisker S., Flyvbjerg A., et al. Ghrelin and its relationship to growth hormones during normal pregnancy. Clin. Endocrinol. (Oxf) 62 (2005) 554-559
20. Casanueva F.F., and Diéguez C. Ghrelin: the link connecting growth with metabolism and energy homeostasis. Rev. Endocr. Metab. Disord. 3 (2002) 325-338
21. Xu H., Barnes G.T., Yang Q., Tan G., Yang B., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
22. Lappas M., Yee K., Permezel M., and Rice G.E. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J. Endocrinol. 186 (2005) 457-465